Health and economic outcomes of the emergence of third-generation cephalosporin resistance in Enterobacter species

Archives of Internal Medicine

Volumn 162, Issue 2, 2002, Pages 185-190

  Cosgrove, Sara E ^a,d   Kaye, Keith S ^b   Eliopoulous, George M ^a   Carmeli, Yehuda ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^d JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEPHALOSPORIN DERIVATIVE;

ADULT; AGE; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DISEASE SEVERITY; ENTEROBACTER; FEMALE; HEALTH CARE COST; HOSPITAL COST; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOMES RESEARCH; PATIENT TRANSPORT; PRIORITY JOURNAL; SEX; SURGERY;

EID: 0037185447     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.162.2.185     Document Type: Article

References (17)

1. National Nosocomial Infections Surveillance (NNIS) report, data summary from October 1986-April 1996, issued May 1996: A report from the National Nosocomial Infections Surveillance (NNIS) System
2. National Nosocomial Infections Surveillance (NNIS) system report, data summary from January 1990-May 1999, issued June 1999
3. Cytosolic intermediates for cell wall biosynthesis and degradation control inducible beta-lactam resistance in gram-negative bacteria
4. Evolution and dissemination of beta-lactamases accelerated by generations of beta-lactam antibiotics
5. Pathogens resistant to antimicrobial agents. Epidemiology, molecular mechanisms, and clinical management
6. Enterobacter bacteremia: Clinical features and emergence of antibiotic resistance during therapy
7. Risk factors for emergence of resistance to broad spectrum cephalosporins among Enterobacter species
8. Health and economic outcomes of antibiotic resistance in Pseudomonas aeruginosa
9. Gram-negative bacteremia
10. Impact of methicillin resistance on the outcome of patients with bacteremia caused by Staphylococcus aureus
11. Bacteremia caused by Enterobacter. 15 Years of experience in a cancer hospital
12. Markedly different rates and resistance profiles exhibited by seven commonly used and newer beta-lactams on the selection of resistant variants of Enterobacter cloacae
13. Development of resistance by Enterobacter cloacae during therapy of pulmonary infections in intensive care patients
14. The relationship between antecedent antibiotic use and resistance to extended-spectrum cephalosporins in group I beta-lactamase-producing organisms
15. Efficacy of cefepime in the treatment of infections due to multiply resistant Enterobacter species